TDOC
Get informed when a big investor buys or sells
+ FollowUndervalued by 231.1% based on the discounted cash flow analysis.
| Market cap | $1.05 Billion |
|---|---|
| Enterprise Value | $1.36 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.14 |
| Beta | 2.14 |
| Outstanding Shares | 180,079,395 |
| P/E Ratio | -5.83 |
|---|---|
| PEG | -30.47 |
| Price to Sales | 0.46 |
| Price to Book Ratio | 0.85 |
| Enterprise Value to Revenue | 0.55 |
| Enterprise Value to EBIT | -8 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.8 |
| Debt to Equity | 0.83 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 73.33% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 86.29% |
|---|---|
| Total Invested | $99,787▼ 99.99% |
| Investors Holding | 9▼ 369.00% |
No data
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized int...